Bilimsel çalışmalar

Prof. Dr. Marıa Del Pılar Laguna Pes

491 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. 383. M.P. Laguna. Re: Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship between Renal Function and Cancer-Specific Mortality in Renal Cell Carcinoma. J Urol. 2019 Jun;201(6):1049-1050

    Kaynak: medipol.com.tr profil sayfası

  2. 384. M.P. Laguna. Re: Diagnostic Needle Biopsies in Renal Masses: Patient and Physician Perspectives. J Urol. 2019 Jul;202(1):28-29

    Kaynak: medipol.com.tr profil sayfası

  3. 385. M.P. Laguna. Re: Axitinib versus Placebo as an Adjuvant Treatment of Renal Cell Carcinoma: Results from the Phase III, Randomized ATLAS Trial. J Urol. 2019 Jul;202(1):27-28

    Kaynak: medipol.com.tr profil sayfası

  4. 386. M.P. Laguna. Re: Variability in Partial Nephrectomy Outcomes: Does Your Surgeon Matter? J Urol. 2019 Aug;202(2):206-207

    Kaynak: medipol.com.tr profil sayfası

  5. 387. M.P. Laguna. Re: Use of Delayed Intervention for Small Renal Masses Initially Managed with Active Surveillance. J Urol. 2019 Aug;202(2):207

    Kaynak: medipol.com.tr profil sayfası

  6. 388. M.P. Laguna. Re: Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma. J Urol. 2019 Sep;202(3):456-457

    Kaynak: medipol.com.tr profil sayfası

  7. 389. M.P. Laguna. Re: Intensive Imaging-Based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-Recurrence Survival: Results from a European Multicentre Database (RECUR). J Urol. 2019 Sep;202(3):455-456

    Kaynak: medipol.com.tr profil sayfası

  8. 391. M.P. Laguna. Re: Comparison of RENAL, PADUA, CSA, and PAVP Nephrometry Scores in Predicting Functional Outcomes after Partial Nephrectomy. J Urol. 2019 Oct;202(4):657-658

    Kaynak: medipol.com.tr profil sayfası

  9. 392. M.P. Laguna. Re: The Prognostic Value of the Site of Invasion in T3aN0M0 Clear Cell Renal Cell Carcinoma. J Urol. 2019 Nov;202(5):863-864

    Kaynak: medipol.com.tr profil sayfası

  10. 393. M.P. Laguna. Re: Development and External Validation of a Nomogram Predicting Prognosis of Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy. J Urol. 2019 Dec;202(6):1093-1094

    Kaynak: medipol.com.tr profil sayfası

  11. 394. M.P. Laguna. Re: Nephrometry Score Correlated with Tumor Proliferative Activity in T1 Clear Cell Renal Cell Carcinoma. J Urol. 2019 Dec;202(6):1094

    Kaynak: medipol.com.tr profil sayfası

  12. 395. M. Shahait, S. Jackman, J. Landman, E. Lechevallier, I. Billiet, L. Fossion, Y. Aslan, M.P. Laguna. Utilization and Operative Influence of Renal Mass Biopsy in the Small Renal Mass: Analysis from the Clinical Research Office of the Endourological Society Small Renal Mass registry. J Endourol. 2020 Jan;34(1):99-106

    Kaynak: medipol.com.tr profil sayfası

  13. 396. L. Sandbergen, A.S. Spriensma, J.J. de la Rosette, M.P. Laguna. Health-related quality of life in localized renal masses: A matter of sparing nephrons or minimizing the incision? Urol Oncol. 2020 Feb;38(2):43.e1-43.e11

    Kaynak: medipol.com.tr profil sayfası

  14. 398. M.P. Laguna. Re: Evaluation of Axitinib to Downstage cT2a Renal Tumours and Allow Partial Nephrectomy: A Phase II Study. J Urol. 2020 Jan;203(1):28-29

    Kaynak: medipol.com.tr profil sayfası

  15. 399. M.P. Laguna. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. J Urol. 2020 Jan;203(1):27-28

    Kaynak: medipol.com.tr profil sayfası

  16. 400. M.P. Laguna. Re: Are There Differences between de Novo and Secondary Upper Tract Urothelial Carcinoma Tumours? J Urol. 2020 Feb;203(2):249-250

    Kaynak: medipol.com.tr profil sayfası

  17. 401. M.P. Laguna. Re: Postoperative Complications Increase the Risk of Long-Term Chronic Kidney Disease after Nephron-Sparing Surgery in Patients with Renal Cancer and Normal Preoperative Renal Function. J Urol. 2020 Feb;203(2):248-249

    Kaynak: medipol.com.tr profil sayfası

  18. 402. M.P. Laguna. Re: The Simplified PADUA REnal (SPARE) Nephrometry System: A Novel Classification of Parenchymal Renal Tumours Suitable for Partial Nephrectomy. J Urol. 2020 Mar;203(3):459-460

    Kaynak: medipol.com.tr profil sayfası

  19. 403. M.P. Laguna. Re: Clinicopathological and Survival Analysis of Clinically Advanced Papillary and Chromophobe Renal Cell Carcinoma. J Urol. 2020 Mar;203(3):460-461.J Urol. 2019 Dec 10:101097JU000000000000067501. doi: 10.1097/JU.0000000000000675.01. [Epub ahead of print]

    Kaynak: medipol.com.tr profil sayfası

  20. 405. J. Mayor, M. Álvarez-Maestro, JÁ Arranz, M.P. Laguna. De-escalation: Testicular cancer. Arch Esp Urol. 2020 Jun;73(5):390-394.

    Kaynak: medipol.com.tr profil sayfası

  21. 406. Y. Kordan, A.E. Canda, E. Köseoğlu, D. Balbay, M.P. Laguna, J.J. de la Rosette. Robotic-Assisted Simple Prostatectomy: A Systematic Review. Clin Med. 2020 Jun 9;9(6):1798.

    Kaynak: medipol.com.tr profil sayfası

  22. 407. M.P. Laguna Re: Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma. J Urol. 2020 May;203(5):877

    Kaynak: medipol.com.tr profil sayfası

  23. 408. M.P. Laguna Re: Effect of Renal Mass Biopsy on Subsequent Nephrectomy Outcomes: A Population-Based Assessment. J Urol. 2020 Jun;203(6):1059-1060.

    Kaynak: medipol.com.tr profil sayfası

  24. 409. M.P. Laguna Urological Oncology: Adrenal, Renal, Ureteral and Retroperitoneal Tumors. J Urol. 2021 Jan;205(1):301-302

    Kaynak: medipol.com.tr profil sayfası

  25. 410. M.P. Laguna Re: Renal Mass Biopsy is Associated with Reduction in Surgery for Early-Stage Kidney Cancer.J Urol. 2020 May;203(5):878

    Kaynak: medipol.com.tr profil sayfası

  26. 411. M.P. Laguna Re: Impact of Hospital Nephrectomy Volume on Intermediate- to Long-Term Survival in Renal Cell Carcinoma. J Urol. 2020 Nov;204(5):1092-1093.

    Kaynak: medipol.com.tr profil sayfası

  27. 412. M.P. Laguna Re: Impact of Acute Kidney Injury and its Duration on Long-Term Renal Function after Partial Nephrectomy. J Urol. 2020 Apr;203(4):658-659

    Kaynak: medipol.com.tr profil sayfası

  28. 413. M.P. Laguna Re: Three-Dimensional Virtual Imaging of Renal Tumours: A New Tool to Improve the Accuracy of Nephrometry Scores.J Urol. 2020 Jul;204(1):182.

    Kaynak: medipol.com.tr profil sayfası

  29. 414. M.P. Laguna Re: Psychological Distress Associated with Active Surveillance in Patients Younger Than 70 with a Small Renal Mass. J Urol. 2020 Dec;204(6):1377

    Kaynak: medipol.com.tr profil sayfası

  30. 415. M.P. Laguna Re: Next-Generation RNA Sequencing-Based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms. J Urol. 2020 Dec;204(6):1376

    Kaynak: medipol.com.tr profil sayfası

  31. 416. M.P. Laguna Re: Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated with either Percutaneous Microwave Ablation or Surgery. J Urol. 2020 Jun;203(6):1058-1059.

    Kaynak: medipol.com.tr profil sayfası

  32. 417. M.P. Laguna Re: Development and Validation of a Robust Multigene Signature as an Aid to Predict Early Relapse in Stage I-III Clear Cell and Papillary Renal Cell Cancer. J Urol. 2020 Oct;204(4):875.

    Kaynak: medipol.com.tr profil sayfası

  33. 418. M.P. Laguna Re: Effect of Obesity and Overweight Status on Complications and Survival after Minimally Invasive Kidney Surgery in Patients with Clinical T2-4 Renal Masses. J Urol. 2020 Aug;204(2):383-384.

    Kaynak: medipol.com.tr profil sayfası

  34. 419. M.P. Laguna Re: Prediction of Significant Estimated Glomerular Filtration Rate Decline after Renal Unit Removal to Aid in the Clinical Choice between Radical and Partial Nephrectomy in Patients with a Renal Mass and Normal Renal Function. J Urol. 2020 Jul;204(1):181

    Kaynak: medipol.com.tr profil sayfası

  35. 420. M.P. Laguna Re: Long-Term Risk of Recurrence in Surgically Treated Renal Cell Carcinoma: A Post Hoc Analysis of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E2805 Trial Cohort. J Urol. 2020 Sep;204(3):614-615.

    Kaynak: medipol.com.tr profil sayfası

  36. 421. M. Amaresh, P. Hegde, A. Chawla, J.J.M.C.H. de la Rosette, M.P. Laguna, A. Kriplani. Safety and efficacy of superior calyceal access versus inferior calyceal access for pelvic and/or lower calyceal renal calculi- a prospective observational comparative study. World J Urol. 2020 Aug 31 doi: 10.1007/s00345-020-03409-3. Online ahead of print.

    Kaynak: medipol.com.tr profil sayfası

  37. 422. M.P. Laguna Re: Transplanting Kidneys from Donors with Small Renal Masses-A Strategy to Expand the Donor Pool. J Urol. 2020 Aug;204(2):382

    Kaynak: medipol.com.tr profil sayfası

  38. 423. M.P. Laguna Re: Chest Computed Tomography for Staging Renal Tumours: Validation and Simplification of a Risk Prediction Model from a Large Contemporary Retrospective Cohort. J Urol. 2020 Nov;204(5):1093-1094

    Kaynak: medipol.com.tr profil sayfası

  39. 424. J. de la Rosette, P. Laguna, M. Álvarez-Maestro, M. Eto, C.A. Mochtar, S. Albayrak, A. Mendoza-Valdes, T.A. Ong, S. Khadgi, A. Al-Terki, D. Bolton, R. Gomez, L. Klotz, S. Kulkarni, S. Tanguay, S. Gravas; Société Internationale d’Urologie Board of Directors. Cross-continental comparison of safety and protection measures amongst urologists during COVID-19. Int J Urol. 2020 Nov;27(11):981-989.

    Kaynak: medipol.com.tr profil sayfası

  40. 425. S. Morselli, A. Liaci, R. Nicoletti, A. Pecoraro, L. Gemma, P. Polverino, C. Zaccaro, A. Sebastianelli, S Serni, P. Laguna, J.J.M.C.H. de La Rosette, S. Gravas, M. Gacci. The use of a novel smartphone app for monitoring male luts treatment during the COVID-19 outbreak. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):724-726.

    Kaynak: medipol.com.tr profil sayfası

  41. 427. S. Yıldırım, D. Shoskes, S. Kulkarni, P. Laguna. Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity?.World J Urol. 2020 Nov;38(11):2721-2731

    Kaynak: medipol.com.tr profil sayfası